Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Eva Löfvenberg"'
Publikováno v:
International Journal of Medical Sciences, Vol 5, Iss 2, Pp 87-91 (2008)
Anagrelide is often used in the treatment of thrombocythemia in myeloproliferative disease (MPD), but information concerning effects of treatment on cytokines involved in regulation of blood platelet levels is limited. Here, we investigated serum lev
Externí odkaz:
https://doaj.org/article/fdeaeea6a9eb4f0b9a31b343a78f7f41
Publikováno v:
European Journal of Haematology. 60:125-132
The activation associated proteins CD23 and CD69 are expressed on cells of different lineages upon mitogenic stimulation. CD23 is a well characterized multifunctional protein in lymphocyte development recognized as a diagnostic marker for chronic lym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a08e798c5673495a78da05b94951905f
https://doi.org/10.1111/j.1600-0609.1998.tb01009.x
https://doi.org/10.1111/j.1600-0609.1998.tb01009.x
Autor:
Eva Löfvenberg, Torbjörn K. Nilsson
Publikováno v:
European Journal of Haematology. 43:435-440
19 consecutive untreated patients with chronic myeloproliferative disorders and thrombocytosis were subjected to comprehensive platelet function tests including platelet aggregometry. 12 patients had essential thrombocythaemia (ET) and 7 patients had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab43e1c5c07278663271f991b1401af4
https://doi.org/10.1111/j.1600-0609.1989.tb00332.x
https://doi.org/10.1111/j.1600-0609.1989.tb00332.x
Autor:
Anders Wahlin, Eva Löfvenberg
Publikováno v:
European Journal of Haematology. 41:375-381
A total of 59 symptomatic patients with myeloproliferative disorders (polycythaemia vera 24 pats., essential thrombocythaemia 25 pats., myelofibrosis 10 pats.) and elevated platelet counts were studied during 1653 months of continuous treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75b88b15b514a7db12d1a4ff49f01b4
https://doi.org/10.1111/j.1600-0609.1988.tb00212.x
https://doi.org/10.1111/j.1600-0609.1988.tb00212.x
Publikováno v:
Acta Medica Scandinavica. 222:169-174
Blood and bone marrow changes induced by continuous low-dose hydroxyurea treatment are described. A linear increase in mean red cell volume was observed after onset of therapy. The entire normocyte population was replaced by abnormally large erythroc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82aba27b5bf92e8a98a6e0cd9cb42545
https://doi.org/10.1111/j.0954-6820.1987.tb10655.x
https://doi.org/10.1111/j.0954-6820.1987.tb10655.x
Autor:
Ulla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, Inger Braide, Karin Carlson, Gösta Gahrton, Gunnar Grimfors, Robert Hast, Rickard Lerner, Olle Linder, Per Ljungman, Eva Löfvenberg, Claes Malm, Per-Gunnar Nilsson, Christer Paul, Stig Rödjer, Leif Stenke, Ulf Tidefeldt, Ingemar Turesson, Ann-Marie Uden, Anders Wahlin, Lars Vilen, Ingemar Winqvist, Olle Zettervall, Gunnar Öberg, Bengt Simonsson, null (For The Swedish Cml Group)
Publikováno v:
Leukemia & Lymphoma. 47:1768-1773
The aim of the study was to investigate the feasibility of mobilizing Philadelphia chromosome negative (Ph-) blood stem cells (BSC) with intensive chemotherapy and lenograstim (G-CSF) in patients with CML in first chronic phase (CP1). During 1994-199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3daeab7df358552087bba2a75856460b
https://doi.org/10.1080/10428190600611117
https://doi.org/10.1080/10428190600611117
Publikováno v:
European Journal of Haematology. 74:489-495
The prevailing attitudes regarding diagnostic and therapeutic procedures in patients with polycythaemia vera (PV) among Swedish haematologists were surveyed by way of a mailed questionnaire in August 2002. Among diagnostic procedures frequent use is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6623ab87d25adbaf7194fbc8257913
https://doi.org/10.1111/j.1600-0609.2005.00424.x
https://doi.org/10.1111/j.1600-0609.2005.00424.x
Autor:
Lars Vilén, Karin Rn Olsson, Mats Björeman, Ulla Olsson-Strömberg, Olle Linder, Gunnar Öberg, Magnus Björkholm, Anders Wahlin, Ann-Marie Uden, Gösta Gahrton, Karin Karlsson, Per Ljungman, Bengt Simonsson, Christer Paul, Jonas Nilsson, Robert Hast, Eva Löfvenberg, Gunnar Grimfors, Johan Lanng Nielsen, Jan Carneskog, Leif Stenke, Hans Karle, Jesper Stentoft, Ingemar Turesson, Ole Weis-Bjerrum, Claes Malm
Publikováno v:
Acta Haematologica. 113:155-162
In the present study we combined interferon (IFN) and hydroxyurea (HU) treatment, intensive chemotherapy and autologous stem cell transplantation (SCT) in newly diagnosed chronic myelogenous leukemia patients aged below 56 years, not eligible for all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f82c5aa96ecc8531729872b0b9c46c
https://doi.org/10.1159/000084445
https://doi.org/10.1159/000084445
Autor:
Olle Vikrot, B. Wadman, Gunnar Öberg, Anders Wahlin, Tomas Ahlgren, Karin Carlsson, Robert Hast, Bengt Simonsson, Christer Paul, Ann-Mari Uden, Stig Rödjer, Olle Linder, Ingemar Turesson, Eva Löfvenberg, Jan Westin, Per Ljungman, Olle Zettervall, Magnus Björkholm, Claes Malm, Gösta Gahrton, Ulla Olsson-Strömberg, Andreas Killander
Publikováno v:
The Hematology Journal. 5:462-466
Whether busulphan-treated patients develop blastic transformation earlier than hydroxyurea treated has been a controversial issue. In a randomised prospective study, we examined the busulphan versus hydroxyurea influence on time to blast crisis and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a6c6f5ea0031bc3d5c8090bd18a182
https://doi.org/10.1038/sj.thj.6200552
https://doi.org/10.1038/sj.thj.6200552
Autor:
Jon-Magnus Tangen, Herman Nilsson-Ehle, Eva Hellström-Lindberg, Ingemar Winquist, Ulf Tidefelt, Robert Hast, Olle Linder, G. Gahrton, Inger Marie S. Dahl, Ingela Turesson, L Ohm, Per Bernell, Gunnar Öberg, C. Paul, Jonas Wallvik, Magnus Björkholm, Richard Lerner, Fredrik Celsing, Greger Lindberg, Eva Löfvenberg, J. Samuelsson, Anders Wahlin, I. Dybedal
Publikováno v:
Leukemia. 17:1827-1833
In this prospective randomized multicenter trial 93 patients, median age 72 years, with RAEB-t (n=25) and myelodysplastic syndrome (MDS)-AML (n=68) were allocated to a standard induction chemotherapy regimen (TAD 2+7) with or without addition of gran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9728f4bad2cb7ff775acf81abd58c98
https://doi.org/10.1038/sj.leu.2403035
https://doi.org/10.1038/sj.leu.2403035